Skip to main navigation
Skip to Content
Overview
News & Events
News Releases
Events & Presentations
Governance
Governance Overview
Executive Leadership
Board of Directors
Committee Composition
Stock Information
Stock Quote & Chart
Historic Price Lookup
Investment Calculator
Analyst Coverage
Financials
SEC Filings
Resources
Investor FAQs
Email Alerts
Contact IR
Search
Your selection
Clear all
News
Remove
Filter by content type
(-)
News
(67)
Filter by content year
2024
(8)
2023
(23)
2022
(17)
2021
(8)
2020
(3)
2019
(1)
2018
(3)
2017
(4)
Filter by form group
Filter by category
Filter by type
Filter by category
Filter by category
Filter by category
Search
News
Tango Therapeutics to Participate in the Jefferies London Healthcare Conference
News
Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates
News
Tango Therapeutics to Participate in Upcoming Investor Conferences
News
Tango Therapeutics to Participate in Upcoming Investor Conferences
News
Tango Therapeutics Announces Presentation of TNG908 Preclinical Combination Data at 2022 ESMO Targeted Anticancer Therapies Congress
News
Tango Therapeutics Announces Presentation of Preclinical Data on TNG908, USP1 Inhibitor Program and Discovery Platform in Three Abstracts Accepted at AACR 2022 Annual Meeting
News
Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights
News
Tango Therapeutics to Participate in the Guggenheim Synthetic Lethality Day 2022
News
Tango Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights
News
Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
Pagination
Page 1
Next page
››
Print
RSS Feeds
Email Alerts
Contact IR